| Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment OJ Wouters, KC Shadlen, M Salcher-Konrad, AJ Pollard, HJ Larson, ... The Lancet 397 (10278), 1023-1034, 2021 | 1329 | 2021 |
| Estimated research and development investment needed to bring a new medicine to market, 2009-2018 OJ Wouters, M McKee, J Luyten JAMA 323 (9), 844-853, 2020 | 1245 | 2020 |
| Early chronic kidney disease: diagnosis, management and models of care OJ Wouters, DJ O'Donoghue, J Ritchie, PG Kanavos, AS Narva Nature Reviews Nephrology 11 (8), 491-502, 2015 | 284 | 2015 |
| Pharmaceutical regulation in 15 European countries: review D Panteli, F Arickx, I Cleemput, G Dedet, H Eckhardt, E Fogarty, ... Health Systems in Transition 18 (5), 1-118, 2016 | 173 | 2016 |
| Comparing generic drug markets in Europe and the United States: prices, volumes, and spending OJ Wouters, PG Kanavos, M McKee The Milbank Quarterly 95 (3), 554-601, 2017 | 165 | 2017 |
| Lobbying expenditures and campaign contributions by the pharmaceutical and health product industry in the United States, 1999-2018 OJ Wouters JAMA Internal Medicine 180 (5), 688-697, 2020 | 100 | 2020 |
| Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic M Jit, A Ananthakrishnan, M McKee, OJ Wouters, P Beutels, ... The Lancet Regional Health Europe 9 (100221), 1-8, 2021 | 69 | 2021 |
| The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period OJ Wouters, DM Sandberg, A Pillay, PG Kanavos Social Science & Medicine 220, 362-370, 2019 | 53 | 2019 |
| Timing and characteristics of cumulative evidence available on novel therapeutic agents receiving Food and Drug Administration accelerated approval H Naci, OJ Wouters, R Gupta, JPA Ioannidis The Milbank Quarterly 95 (2), 261-290, 2017 | 45 | 2017 |
| A comparison of generic drug prices in seven European countries: a methodological analysis OJ Wouters, PG Kanavos BMC Health Services Research 17 (1), 242, 2017 | 39 | 2017 |
| An assessment of the methodological quality of published network meta-analyses: a systematic review JD Chambers, H Naci, OJ Wouters, J Pyo, S Gunjal, IR Kennedy, ... PLoS One 10 (4), e0121715, 2015 | 38 | 2015 |
| High drug prices are not justified by industry’s spending on research and development A Angelis, R Polyakov, OJ Wouters, E Torreele, M McKee BMJ 380, e071710, 2023 | 37 | 2023 |
| QALYs in cost-effectiveness analysis: an overview for cardiologists OJ Wouters, H Naci, NJ Samani Heart 101 (23), 1868-1873, 2015 | 37 | 2015 |
| Medical savings accounts: assessing their impact on efficiency, equity, and financial protection in health care OJ Wouters, J Cylus, W Yang, S Thomson, M McKee Health Economics, Policy and Law 11 (3), 321-335, 2016 | 34 | 2016 |
| The Challenges of Regulating Artificial Intelligence in Healthcare: Comment on" Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It … M McKee, OJ Wouters International journal of health policy and management 12, 2023 | 30 | 2023 |
| Measuring health science research and development in Africa: mapping the available data C Wenham, O Wouters, C Jones, PA Juma, RM Mijumbi-Deve, ... Health Research Policy and Systems 19, 1-13, 2021 | 26 | 2021 |
| Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform OJ Wouters, PG Kanavos Bulletin of the World Health Organization 93 (9), 606-613, 2015 | 26 | 2015 |
| Private financing of health care in times of economic crisis: a review of the evidence OJ Wouters, M McKee Global Policy 8 (S2), 23-29, 2016 | 25 | 2016 |
| Association of research and development investments with treatment costs for new drugs approved from 2009 to 2018 OJ Wouters, LA Berenbrok, M He, Y Li, I Hernandez JAMA Network Open 5 (9), e2218623, 2022 | 24 | 2022 |
| Competition issues in the distribution of pharmaceuticals P Kanavos, O Wouters In: OECD Global Forum on Competition, 27-28 Feb 2014, Paris, France, 2014 | 21 | 2014 |
Martin McKeeProfessor of European Public Health, London School of Hygiene and Tropical Medicine在 lshtm.ac.uk 的电子邮件经过验证
